A cancer drug may help save limbs in people with peripheral artery disease. The condition is associated with various complications, including high-risk diabetes and amputations, and is being addressed through medical research and new treatments. The development of innovative treatments, including a potentially FDA-approved option, aims to improve patient outcomes and reduce the need for amputations.